Next-generation proteomics accelerating precision oncology drug pipelines
Advancements in next-generation proteomics are transforming the landscape of precision oncology by enabling deeper, faster, and more accurate analysis of
Top Stories
Get the free newsletter
Top news, trends & analysis from Biomed Today.
No spam · Unsubscribe anytime
Research Highlights
Sponsored Research
Partner Content
- Dr. Elena Marchetti
- MIT — Dept. of Biological Engineering
- Nature Methods · Mar 2026
Biotech
Perspective
Featured
"The tumour microenvironment is not just a bystander — it's an active participant in immune evasion. Understanding that changed everything about how we design therapies."
SC
Prof. Sarah Chen
Director of Immuno-oncology · Francis Crick Institute
"Precision is no longer the bottleneck — delivery is."
dr
Dr. Ravi Menon
Broad Institute
"The judgement to use these tools well still requires a trained mind."
al
Prof. Amara Levi
Novartis Research
Perspectives from leading researchers worldwide
Resources
Opportunities
24 new this week
Events
Upcoming
Trendline
Sponsored
Next-generation proteomics accelerating precision oncology drug pipelines
Advancements in next-generation proteomics are transforming the landscape of precision oncology by enabling deeper, faster, and more accurate analysis of protein expression and function. Unlike traditional genomic approaches, proteomics provides direct insight into the dynamic molecular processes driving cancer progression, offering a clearer picture of disease biology. Novel proteomic platforms